Sitagliptin-Induced Arthralgias: A Case Report
Case Presentation
On 14 August 2018, B.F., a 56-year-old woman, reported to the clinic for a pharmacist-led diabetes education session secondary to a visit with her provider on the same day. The patient had been diagnosed with type 2 diabetes on 29 May 2018 after completing routine laboratory testing 5 days earlier and was started on the combination therapy sitagliptin/metformin 50/1,000 mg twice daily. B.F.’s laboratory test values drawn on 24 May 2018 are shown in Table 1, and her medication history through the day of the education session is shown in Table 2. The patient was switched from sitagliptin/metformin to sitagliptin 100 mg once daily on 22 June 2018 because she had symptoms including upset stomach, diarrhea, and indigestion from the metformin component of the combination therapy.
- In this window
- In a new window
B.F.’s Laboratory Test Values on 24 May 2018
- In this window
- In a new window
B.F.’s Medication History
During her 14 August 2018 diabetes education session, B.F. revealed that she had been experiencing some neuropathy in her feet and that she had been checking her glucose regularly in the morning (with levels usually ∼200 mg/dL). Her last eye exam had been 2 years prior, and she had not yet had a diabetic foot exam. She then reported that 3 weeks into taking the sitagliptin, she began experiencing bad and worsening joint …
Log in using your username and password
Purchase access
